Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.

Luz PM, Osher B, Grinsztejn B, Maclean RL, Losina E, Stern ME, Struchiner CJ, Parker RA, Freedberg KA, Mesquita F, Walensky RP, Veloso VG, Paltiel AD.

J Int AIDS Soc. 2018 Mar;21(3):e25096. doi: 10.1002/jia2.25096.

2.

Congenital CMV and HIV Perinatal Transmission.

Adachi K, Xu J, Ank B, Watts DH, Camarca M, Mofenson LM, Pilotto JH, Joao E, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Machado DM, Ceriotto M, Morgado MG, Bryson YJ, Veloso VG, Grinsztejn B, Mirochnick M, Moye J, Nielsen-Saines K; NICHD HPTN 040 Study Team.

Pediatr Infect Dis J. 2018 Mar 9. doi: 10.1097/INF.0000000000001975. [Epub ahead of print]

PMID:
29528912
3.

Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.

Grinsztejn B, Hoagland B, Moreira RI, Kallas EG, Madruga JV, Goulart S, Leite IC, Freitas L, Martins LMS, Torres TS, Vasconcelos R, De Boni RB, Anderson PL, Liu A, Luz PM, Veloso VG; PrEP Brasil Study Team.

Lancet HIV. 2018 Mar;5(3):e136-e145. doi: 10.1016/S2352-3018(18)30008-0. Epub 2018 Feb 18.

PMID:
29467098
4.

Syndemics among individuals enrolled in the PrEP Brasil Study.

De Boni RB, Machado IK, De Vasconcellos MTL, Hoagland B, Kallas EG, Madruga JV, Fernandes NM, Cerqueira NB, Moreira RI, Goulart SP, Veloso VG, Grinsztejn B, Luz PM.

Drug Alcohol Depend. 2018 Apr 1;185:168-172. doi: 10.1016/j.drugalcdep.2017.12.016. Epub 2018 Feb 10.

PMID:
29454927
5.

Awareness of Prevention Strategies and Willingness to Use Preexposure Prophylaxis in Brazilian Men Who Have Sex With Men Using Apps for Sexual Encounters: Online Cross-Sectional Study.

Torres TS, De Boni RB, de Vasconcellos MT, Luz PM, Hoagland B, Moreira RI, Veloso VG, Grinsztejn B.

JMIR Public Health Surveill. 2018 Jan 22;4(1):e11. doi: 10.2196/publichealth.8997.

6.

Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission.

Adachi K, Xu J, Yeganeh N, Camarca M, Morgado MG, Watts DH, Mofenson LM, Veloso VG, Pilotto JH, Joao E, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M, Machado DM, Bryson YJ, Grinsztejn B, Moye J, Klausner JD, Bristow CC, Dickover R, Mirochnick M, Nielsen-Saines K; NICHD HPTN 040 Study Team.

PLoS One. 2018 Jan 5;13(1):e0189851. doi: 10.1371/journal.pone.0189851. eCollection 2018.

7.

Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil.

Moreira J, Castro R, Lamas C, Ribeiro S, Grinsztejn B, Veloso VG.

Int J Infect Dis. 2018 Apr;69:11-19. doi: 10.1016/j.ijid.2017.12.014. Epub 2017 Dec 15.

8.

Hybrid capture as a tool for cervical lesions screening in HIV-infected women: insights from a Brazilian cohort.

Jalil EM, Luz PM, Quintana M, Friedman RK, Madeira RMDS, Andrade AC, Chicarino J, Moreira RI, Derrico M, Levi JE, Russomano F, Veloso VG, Grinsztejn B.

Braz J Infect Dis. 2018 Jan - Feb;22(1):16-23. doi: 10.1016/j.bjid.2017.10.007. Epub 2017 Dec 6.

9.

Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil.

Perazzo H, Jorge MJ, Silva JC, Avellar AM, Silva PS, Romero C, Veloso VG, Mujica-Mota R, Anderson R, Hyde C, Castro R.

BMC Gastroenterol. 2017 Nov 23;17(1):119. doi: 10.1186/s12876-017-0676-8.

10.

Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approach.

Oliveira RVC, Shimakura SE, Campos DP, Hökerberg YHM, Victoriano FP, Ribeiro S, Veloso VG, Grinsztejn B, Carvalho MS.

AIDS Care. 2018 May;30(5):551-559. doi: 10.1080/09540121.2017.1391984. Epub 2017 Oct 23.

PMID:
29058481
11.

HIV testing and the care continuum among transgender women: population estimates from Rio de Janeiro, Brazil.

Jalil EM, Wilson EC, Luz PM, Velasque L, Moreira RI, Castro CV, Monteiro L, Garcia ACF, Cardoso SW, Coelho LE, McFarland W, Liu AY, Veloso VG, Buchbinder S, Grinsztejn B.

J Int AIDS Soc. 2017 Sep 19;20(1):21873. doi: 10.7448/IAS.20.1.21873.

12.

Age-standardized mortality rates related to viral hepatitis in Brazil.

Perazzo H, Pacheco AG, Luz PM, Castro R, Hyde C, Fittipaldi J, Rigolon C, Cardoso SW, Grinsztejn B, Veloso VG.

BMC Infect Dis. 2017 Jul 31;17(1):527. doi: 10.1186/s12879-017-2619-y.

13.

Towards an ideal antiretroviral regimen for the global HIV epidemic.

Grinsztejn B, Coelho LE, Luz PM, Veloso VG.

J Virus Erad. 2017 Jul 1;3(3):111-116.

14.

Asymptomatic anorectal Chlamydia trachomatis and Neisseria gonorrhoeae infections are associated with systemic CD8+ T-cell activation.

Vieira VA, Avelino-Silva VI, Cerqueira NB, Costa DA, Costa PR, Vasconcelos RP, Madruga VR, Moreira RI, Hoagland B, Veloso VG, Grinsztejn B, Kallás EG; PrEP Brasil Study Team.

AIDS. 2017 Sep 24;31(15):2069-2076. doi: 10.1097/QAD.0000000000001580.

PMID:
28692536
15.

Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study.

Lamas CC, Coelho LE, Grinsztejn BJ, Veloso VG.

Infection. 2017 Dec;45(6):801-809. doi: 10.1007/s15010-017-1041-0. Epub 2017 Jun 28.

16.

Substance use among HIV-infected patients in Rio de Janeiro, Brazil: Agreement between medical records and the ASSIST questionnaire.

Machado IK, Luz PM, Lake JE, Castro R, Velasque L, Clark JL, Veloso VG, Grinsztejn B, De Boni RB.

Drug Alcohol Depend. 2017 Sep 1;178:115-118. doi: 10.1016/j.drugalcdep.2017.04.033. Epub 2017 Jun 16.

17.

Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil.

Martin D, Luz PM, Lake JE, Clark JL, Campos DP, Veloso VG, Moreira RI, Cardoso SW, Klausner JD, Grinsztejn B.

J Int AIDS Soc. 2017 Jun 5;20(1):21405. doi: 10.7448/IAS.20.1.21405.

18.

Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death.

da Silva Escada RO, Velasque L, Ribeiro SR, Cardoso SW, Marins LMS, Grinsztejn E, da Silva Lourenço MC, Grinsztejn B, Veloso VG.

BMC Infect Dis. 2017 May 30;17(1):373. doi: 10.1186/s12879-017-2473-y.

19.

Transmitted drug resistance in patients with acute/recent HIV infection in Brazil.

Ferreira ACG, Coelho LE, Grinsztejn E, Jesus CS, Guimarães ML, Veloso VG, Grinsztejn B, Cardoso SW.

Braz J Infect Dis. 2017 Jul - Aug;21(4):396-401. doi: 10.1016/j.bjid.2017.03.013. Epub 2017 May 21.

20.

Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.

de Azevedo SSD, Caetano DG, Côrtes FH, Teixeira SLM, Dos Santos Silva K, Hoagland B, Grinsztejn B, Veloso VG, Morgado MG, Bello G.

Retrovirology. 2017 May 2;14(1):29. doi: 10.1186/s12977-017-0354-5.

21.

High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.

Hoagland B, Moreira RI, De Boni RB, Kallas EG, Madruga JV, Vasconcelos R, Goulart S, Torres TS, Marins LMS, Anderson PL, Luz PM, Costa Leite ID, Liu AY, Veloso VG, Grinsztejn B; PrEP Brasil Study TeamClinical Trial Number 01989611.

J Int AIDS Soc. 2017 Apr 6;20(1):21472. doi: 10.7448/IAS.20.1.21472.

22.

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.

Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RD, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Justice AC, Tate JP, Gill J, Pacheco A, Veloso VG, Bucher HC, Egger M, Furrer H, Porter K, Touloumi G, Crane H, Miro JM, Sterne JA, Costagliola D, Saag M, Hernán MA; HIV-CAUSAL Collaboration; Centers for AIDS Research Network of Integrated Clinical Systems.

Lancet HIV. 2017 Jun;4(6):e251-e259. doi: 10.1016/S2352-3018(17)30043-7. Epub 2017 Apr 11.

PMID:
28411091
23.

International Sexual Partnerships May Be Shaped by Sexual Histories and Socioeconomic Status.

Truong HM, Mehrotra M, Montoya O, Lama JR, Guanira JV, Casapía M, Veloso VG, Buchbinder SP, Mayer KH, Chariyalertsak S, Schechter M, Bekker LG, Kallás EG, Grant RM.

Sex Transm Dis. 2017 May;44(5):306-309. doi: 10.1097/OLQ.0000000000000601.

PMID:
28407648
24.

Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection.

Adachi K, Xu J, Ank B, Watts DH, Mofenson LM, Pilotto JH, Joao E, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Gray G, Theron G, Morgado MG, Bryson YJ, Veloso VG, Klausner JD, Moye J, Nielsen-Saines K; NICHD HPTN 040 Study Team.

Clin Infect Dis. 2017 Aug 1;65(3):405-413. doi: 10.1093/cid/cix222.

PMID:
28369278
25.

Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection.

Couto I, Victoria M, Veloso VG, Rodrigues L, Grinsztejn B, Lacerda M, Victoria F, Perazzo H.

PLoS One. 2017 Mar 22;12(3):e0174453. doi: 10.1371/journal.pone.0174453. eCollection 2017.

26.

Thirty-day Readmission Rates in an HIV-infected Cohort From Rio de Janeiro, Brazil.

Coelho LE, Ribeiro SR, Japiassu AM, Moreira RI, Lara PC, Veloso VG, Grinsztejn B, Luz PM.

J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):e90-e98. doi: 10.1097/QAI.0000000000001352.

PMID:
28291051
27.

Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil.

Grinsztejn B, Jalil EM, Monteiro L, Velasque L, Moreira RI, Garcia AC, Castro CV, Krüger A, Luz PM, Liu AY, McFarland W, Buchbinder S, Veloso VG, Wilson EC; Transcender Study Team.

Lancet HIV. 2017 Apr;4(4):e169-e176. doi: 10.1016/S2352-3018(17)30015-2. Epub 2017 Feb 8.

28.

Self-rated health and substance use among individuals in HIV care in Rio de Janeiro, Brazil: a cross-sectional study.

Machado IK, Luz PM, Lake JE, Castro R, Velasque L, Clark JL, Veloso VG, Grinsztejn B, De Boni RB.

Int J STD AIDS. 2017 Oct;28(12):1175-1183. doi: 10.1177/0956462417692278. Epub 2017 Feb 2.

29.

Hospitalization rates, length of stay and in-hospital mortality in a cohort of HIV infected patients from Rio de Janeiro, Brazil.

Coelho LE, Ribeiro SR, Veloso VG, Grinsztejn B, Luz PM.

Braz J Infect Dis. 2017 Mar - Apr;21(2):190-195. doi: 10.1016/j.bjid.2016.10.007. Epub 2016 Dec 3.

30.

Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.

Coelho L, Grinsztejn B, Castilho JL, De Boni R, Quintana MS, Campos DP, Ribeiro SR, Pacheco AG, Veloso VG, Luz PM.

Lancet HIV. 2016 Oct;3(10):e490-8. doi: 10.1016/S2352-3018(16)30052-2. Epub 2016 Aug 17.

31.

Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil.

Hoagland B, De Boni RB, Moreira RI, Madruga JV, Kallas EG, Goulart SP, Cerqueira N, Torres TS, Luz PM, Fernandes NM, Liu AY, Grinsztejn B, Veloso VG; PrEP Brasil Study Team.

AIDS Behav. 2017 May;21(5):1278-1287. doi: 10.1007/s10461-016-1516-5.

PMID:
27531461
32.

Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study.

Diaz CM, Segura ER, Luz PM, Clark JL, Ribeiro SR, De Boni R, Eksterman L, Moreira R, Currier JS, Veloso VG, Grinsztejn B, Lake JE.

BMC Infect Dis. 2016 Aug 8;16:376. doi: 10.1186/s12879-016-1735-4.

33.

Poor retention in early care increases risk of mortality in a Brazilian HIV-infected clinical cohort.

Teixeira da Silva DS, Luz PM, Lake JE, Cardoso SW, Ribeiro S, Moreira RI, Clark JL, Veloso VG, Grinsztejn B, De Boni RB.

AIDS Care. 2017 Feb;29(2):263-267. Epub 2016 Jul 27.

34.

HIV Infection Is Not Associated with Carotid Intima-Media Thickness in Brazil: A Cross-Sectional Analysis from the INI/ELSA-Brasil Study.

Pacheco AG, Grinsztejn B, Fonseca Mde J, Griep RH, Lotufo P, Bensenor I, Mill JG, Moreira Rde C, Moreira RI, Friedman RK, Santini-Oliveira M, Cardoso SW, Veloso VG, Chor D.

PLoS One. 2016 Jul 8;11(7):e0158999. doi: 10.1371/journal.pone.0158999. eCollection 2016.

35.

Diabetes Mellitus is Associated with Increased Death Rates Among HIV-Infected Patients in Rio de Janeiro, Brazil.

Moreira RC, Pacheco AG, Paula A, Cardoso SW, Moreira RI, Ribeiro SR, Nunes EP, Guimarães MR, Mello FC, Veloso VG, Grinsztejn B.

AIDS Res Hum Retroviruses. 2016 Dec;32(12):1210-1218. Epub 2016 Jul 14.

PMID:
27329066
36.

The Men Who Have Sex with Men HIV Care Cascade in Rio de Janeiro, Brazil.

Castro R, Ribeiro-Alves M, Corrêa RG, Derrico M, Lemos K, Grangeiro JR, Jesus Bd, Pires D, Veloso VG, Grinsztejn B.

PLoS One. 2016 Jun 14;11(6):e0157309. doi: 10.1371/journal.pone.0157309. eCollection 2016.

37.

Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes.

Adachi K, Klausner JD, Xu J, Ank B, Bristow CC, Morgado MG, Watts DH, Weir F, Persing D, Mofenson LM, Veloso VG, Pilotto JH, Joao E, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M, Machado DM, Bryson YJ, Grinsztejn B, Bastos FI, Siberry G, Nielsen-Saines K; NICHD HPTN 040 Study Team.

Pediatr Infect Dis J. 2016 Aug;35(8):894-900. doi: 10.1097/INF.0000000000001199.

38.

Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients.

Nicol AF, Brunette LL, Nuovo GJ, Grinsztejn B, Friedman RK, Veloso VG, Cunha CB, Coutinho JR, Vianna-Andrade C, Oliveira NS, Woodham AW, DA Silva DM, Kast WM.

J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):27-33. doi: 10.1097/QAI.0000000000001049.

39.

PrEP adherence among trans women in Brazil-access needed for this key population.

Wilson EC, Jalil E, Siqueira BH, Moreira RI, Veloso VG, Monteiro L, Grinsztejn B.

Lancet HIV. 2016 May;3(5):e200. doi: 10.1016/S2352-3018(16)30022-4. No abstract available.

PMID:
27126485
40.

The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study.

Mehrotra ML, Glidden DV, McMahan V, Amico KR, Hosek S, Defechereux P, Mayer KH, Veloso VG, Bekker LG, Avelino-Silva VI, Schechter M, Grant RM.

AIDS Behav. 2016 Jul;20(7):1527-34. doi: 10.1007/s10461-016-1415-9.

41.

Survival benefits of antiretroviral therapy in Brazil: a model-based analysis.

Luz PM, Girouard MP, Grinsztejn B, Freedberg KA, Veloso VG, Losina E, Struchiner CJ, MacLean RL, Parker RA, Paltiel AD, Walensky RP.

J Int AIDS Soc. 2016 Mar 29;19(1):20623. doi: 10.7448/IAS.19.1.20623. eCollection 2016.

42.

Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.

Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, Kirui FK, Badal-Faesen S, Lagat D, Nyirenda M, Naidoo K, Hakim J, Mugyenyi P, Henostroza G, Leger PD, Lama JR, Mohapi L, Alave J, Mave V, Veloso VG, Pillay S, Kumarasamy N, Bao J, Hogg E, Jones L, Zolopa A, Kumwenda J, Gupta A; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team.

Lancet. 2016 Mar 19;387(10024):1198-209. doi: 10.1016/S0140-6736(16)00546-8.

43.

Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.

Coelho LE, Cardoso SW, Amancio RT, Moreira RI, Ribeiro SR, Coelho AB, Campos DP, Veloso VG, Grinsztejn B, Luz PM.

BMC Infect Dis. 2016 Mar 22;16:134. doi: 10.1186/s12879-016-1462-x.

44.

Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study.

Amico KR, Mehrotra M, Avelino-Silva VI, McMahan V, Veloso VG, Anderson P, Guanira J, Grant R; iPrEx Study Team.

AIDS Behav. 2016 Jul;20(7):1535-40. doi: 10.1007/s10461-016-1360-7.

45.

Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography.

Perazzo H, Veloso VG, Grinsztejn B, Hyde C, Castro R.

Int J Hepatol. 2015;2015:624596. doi: 10.1155/2015/624596. Epub 2015 Dec 6. Review.

46.

Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective.

Castro R, Perazzo H, Grinsztejn B, Veloso VG, Hyde C.

Int J Hepatol. 2015;2015:852968. doi: 10.1155/2015/852968. Epub 2015 Nov 29. Review.

47.

First detection of autochthonous Zika virus transmission in a HIV-infected patient in Rio de Janeiro, Brazil.

Calvet GA, Filippis AM, Mendonça MC, Sequeira PC, Siqueira AM, Veloso VG, Nogueira RM, Brasil P.

J Clin Virol. 2016 Jan;74:1-3. doi: 10.1016/j.jcv.2015.11.014. Epub 2015 Nov 23.

PMID:
26615388
48.

Authors' Reply: Is Genotype Testing Really Cost-Effective for Primary Resistance in Brazil?

Luz PM, Grinsztejn B, Veloso VG, Paltiel AD.

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):e56. doi: 10.1097/QAI.0000000000000902. No abstract available.

49.

Retention in Early Care at an HIV Outpatient Clinic in Rio de Janeiro, Brazil, 2000-2013.

Silva DS, De Boni RB, Lake JE, Cardoso SW, Ribeiro S, Moreira RI, Clark JL, Veloso VG, Grinsztejn B, Luz PM.

AIDS Behav. 2016 May;20(5):1039-48. doi: 10.1007/s10461-015-1235-3.

50.

Time trend analysis of cervical high-risk human papillomavirus (HPV) in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil: the rise of non-16/18 HPV.

Cambou MC, Levi JE, Lake JE, de Andrade A, Jalil EM, Russomano F, Derrico M, Veloso VG, Friedman RK, Luz PM, Grinsztejn B.

Int J Infect Dis. 2015 Dec;41:17-20. doi: 10.1016/j.ijid.2015.10.017. Epub 2015 Oct 28.

Supplemental Content

Loading ...
Support Center